Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peroxiredoxin VI | 13 | 2014 | 18 | 1.860 |
Why?
|
Peroxidases | 13 | 2013 | 28 | 1.550 |
Why?
|
Oxidative Stress | 20 | 2018 | 718 | 1.110 |
Why?
|
Glutathione | 16 | 2018 | 343 | 0.920 |
Why?
|
Peroxiredoxins | 16 | 2022 | 34 | 0.910 |
Why?
|
Glutathione Transferase | 7 | 2016 | 166 | 0.850 |
Why?
|
Signal Transduction | 8 | 2018 | 2689 | 0.760 |
Why?
|
Lung | 15 | 2007 | 849 | 0.740 |
Why?
|
Reactive Oxygen Species | 14 | 2019 | 499 | 0.710 |
Why?
|
Isoflavones | 2 | 2019 | 31 | 0.710 |
Why?
|
Oxidation-Reduction | 16 | 2022 | 567 | 0.690 |
Why?
|
Endothelium, Vascular | 8 | 2009 | 371 | 0.610 |
Why?
|
Nitric Oxide | 8 | 2014 | 382 | 0.590 |
Why?
|
Phospholipases A2 | 5 | 2009 | 32 | 0.580 |
Why?
|
Energy Metabolism | 3 | 2019 | 222 | 0.550 |
Why?
|
Ischemia | 6 | 2005 | 229 | 0.510 |
Why?
|
Glutathione S-Transferase pi | 6 | 2018 | 53 | 0.510 |
Why?
|
Hydrogen Peroxide | 6 | 2013 | 168 | 0.500 |
Why?
|
Azo Compounds | 3 | 2010 | 33 | 0.490 |
Why?
|
Calcium | 8 | 2016 | 929 | 0.480 |
Why?
|
Lung Neoplasms | 4 | 2019 | 1172 | 0.450 |
Why?
|
Cell Membrane | 3 | 2012 | 524 | 0.440 |
Why?
|
Nitric Oxide Synthase | 3 | 2014 | 163 | 0.430 |
Why?
|
Mitochondria | 5 | 2019 | 643 | 0.380 |
Why?
|
Brain Injuries | 1 | 2014 | 268 | 0.370 |
Why?
|
Recovery of Function | 1 | 2014 | 506 | 0.370 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2014 | 282 | 0.340 |
Why?
|
Animals | 40 | 2022 | 20880 | 0.340 |
Why?
|
Mice | 28 | 2022 | 8474 | 0.310 |
Why?
|
Protein Processing, Post-Translational | 6 | 2019 | 284 | 0.310 |
Why?
|
Proteasome Inhibitors | 2 | 2018 | 29 | 0.310 |
Why?
|
Phospholipases | 1 | 2007 | 12 | 0.300 |
Why?
|
Cell Line, Tumor | 9 | 2019 | 1851 | 0.290 |
Why?
|
Protein Binding | 7 | 2016 | 1027 | 0.290 |
Why?
|
Cysteine | 5 | 2022 | 112 | 0.280 |
Why?
|
Pulmonary Circulation | 2 | 2005 | 79 | 0.280 |
Why?
|
NADPH Oxidases | 3 | 2005 | 80 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2019 | 332 | 0.250 |
Why?
|
Rats | 15 | 2011 | 5300 | 0.250 |
Why?
|
Protein Disulfide-Isomerases | 2 | 2018 | 27 | 0.240 |
Why?
|
Endothelial Cells | 5 | 2010 | 384 | 0.230 |
Why?
|
Biomarkers | 3 | 2019 | 1593 | 0.220 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 9 | 0.210 |
Why?
|
Rad51 Recombinase | 1 | 2022 | 16 | 0.210 |
Why?
|
Humans | 34 | 2022 | 68549 | 0.210 |
Why?
|
para-Aminobenzoates | 3 | 2010 | 27 | 0.210 |
Why?
|
Apoptosis | 8 | 2019 | 1641 | 0.210 |
Why?
|
Kinetics | 6 | 2010 | 1047 | 0.200 |
Why?
|
Serpins | 3 | 2019 | 205 | 0.200 |
Why?
|
Unfolded Protein Response | 3 | 2019 | 70 | 0.200 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 2 | 2012 | 20 | 0.200 |
Why?
|
Phospholipids | 6 | 2007 | 108 | 0.190 |
Why?
|
Membrane Proteins | 3 | 2011 | 617 | 0.190 |
Why?
|
Neoplasms | 6 | 2014 | 1664 | 0.190 |
Why?
|
Hyperoxia | 3 | 2006 | 27 | 0.190 |
Why?
|
Multiple Myeloma | 2 | 2018 | 92 | 0.180 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 1070 | 0.180 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2019 | 48 | 0.170 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 40 | 0.170 |
Why?
|
Mice, Knockout | 10 | 2018 | 1692 | 0.170 |
Why?
|
Indenes | 1 | 2018 | 6 | 0.160 |
Why?
|
Models, Molecular | 4 | 2012 | 546 | 0.160 |
Why?
|
Oxygen | 3 | 2006 | 386 | 0.160 |
Why?
|
Sulfhydryl Compounds | 4 | 2013 | 73 | 0.160 |
Why?
|
Circular Dichroism | 2 | 2009 | 99 | 0.160 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 53 | 0.160 |
Why?
|
Glutaminase | 1 | 2017 | 7 | 0.150 |
Why?
|
Thiadiazoles | 1 | 2017 | 7 | 0.150 |
Why?
|
Endoplasmic Reticulum | 2 | 2016 | 148 | 0.150 |
Why?
|
Benzeneacetamides | 1 | 2017 | 11 | 0.150 |
Why?
|
NF-kappa B | 2 | 2014 | 432 | 0.150 |
Why?
|
Mice, Inbred C57BL | 10 | 2018 | 2791 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 65 | 0.150 |
Why?
|
Oligopeptides | 1 | 2017 | 152 | 0.140 |
Why?
|
HL-60 Cells | 3 | 2010 | 50 | 0.140 |
Why?
|
4-Aminobenzoic Acid | 3 | 2010 | 30 | 0.140 |
Why?
|
Mutation | 3 | 2012 | 1213 | 0.140 |
Why?
|
Protein S | 1 | 2016 | 9 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2018 | 201 | 0.140 |
Why?
|
Extracellular Space | 1 | 2016 | 121 | 0.130 |
Why?
|
Glycolysis | 1 | 2016 | 79 | 0.130 |
Why?
|
MCF-7 Cells | 2 | 2013 | 80 | 0.130 |
Why?
|
Homeostasis | 3 | 2014 | 291 | 0.130 |
Why?
|
Phospholipases A | 2 | 2005 | 41 | 0.130 |
Why?
|
Cells, Cultured | 5 | 2010 | 2673 | 0.130 |
Why?
|
Alleles | 2 | 2014 | 386 | 0.130 |
Why?
|
Drug Discovery | 1 | 2016 | 94 | 0.130 |
Why?
|
Cell Line | 5 | 2016 | 1752 | 0.130 |
Why?
|
Immunoblotting | 3 | 2010 | 254 | 0.120 |
Why?
|
Cell Movement | 2 | 2014 | 630 | 0.120 |
Why?
|
Lipid Peroxidation | 2 | 2012 | 94 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2014 | 65 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2014 | 83 | 0.120 |
Why?
|
Spectrometry, Fluorescence | 3 | 2009 | 112 | 0.120 |
Why?
|
Bone Marrow | 1 | 2014 | 168 | 0.120 |
Why?
|
Glutathione Disulfide | 2 | 2012 | 31 | 0.110 |
Why?
|
Fibroblasts | 3 | 2022 | 902 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2005 | 1663 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2013 | 3 | 0.110 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2013 | 5 | 0.110 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 778 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2018 | 1174 | 0.110 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 307 | 0.110 |
Why?
|
Tubulin | 1 | 2013 | 60 | 0.110 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2013 | 40 | 0.110 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2012 | 4 | 0.110 |
Why?
|
Cytoprotection | 1 | 2012 | 39 | 0.110 |
Why?
|
Transgenes | 1 | 2012 | 92 | 0.110 |
Why?
|
Cisplatin | 2 | 2012 | 192 | 0.110 |
Why?
|
Cell Membrane Permeability | 1 | 2012 | 59 | 0.110 |
Why?
|
Glutathione Peroxidase | 3 | 2007 | 39 | 0.110 |
Why?
|
Thioredoxins | 2 | 2009 | 26 | 0.110 |
Why?
|
S100 Proteins | 1 | 2012 | 42 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 113 | 0.110 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 134 | 0.100 |
Why?
|
alpha 1-Antichymotrypsin | 1 | 2012 | 7 | 0.100 |
Why?
|
Cellular Senescence | 1 | 2013 | 112 | 0.100 |
Why?
|
Activating Transcription Factor 6 | 1 | 2011 | 6 | 0.100 |
Why?
|
alpha 1-Antitrypsin | 1 | 2012 | 61 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2019 | 659 | 0.100 |
Why?
|
Substrate Specificity | 2 | 2009 | 234 | 0.100 |
Why?
|
Piperazines | 1 | 2013 | 206 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2009 | 272 | 0.100 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 301 | 0.100 |
Why?
|
Acetylcysteine | 1 | 2014 | 296 | 0.100 |
Why?
|
Sphingosine N-Acyltransferase | 1 | 2011 | 62 | 0.100 |
Why?
|
Oxidoreductases | 1 | 2011 | 117 | 0.100 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 332 | 0.090 |
Why?
|
Structure-Activity Relationship | 3 | 2009 | 420 | 0.090 |
Why?
|
Liposomes | 2 | 2009 | 107 | 0.090 |
Why?
|
Hydrolysis | 2 | 2008 | 144 | 0.090 |
Why?
|
Models, Biological | 3 | 2016 | 981 | 0.090 |
Why?
|
Catalysis | 2 | 2008 | 123 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 163 | 0.090 |
Why?
|
Nitric Oxide Donors | 1 | 2010 | 54 | 0.090 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 107 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2007 | 742 | 0.090 |
Why?
|
Obstetric Labor Complications | 1 | 2010 | 20 | 0.090 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2010 | 201 | 0.090 |
Why?
|
Cell Compartmentation | 1 | 2009 | 41 | 0.090 |
Why?
|
Electron Transport Complex I | 1 | 2009 | 20 | 0.090 |
Why?
|
Chorioamnionitis | 1 | 2010 | 40 | 0.090 |
Why?
|
Pulmonary Alveoli | 2 | 2009 | 62 | 0.090 |
Why?
|
Prodrugs | 1 | 2010 | 54 | 0.090 |
Why?
|
RNA Interference | 1 | 2010 | 266 | 0.090 |
Why?
|
Sulfonamides | 1 | 2010 | 141 | 0.090 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 102 | 0.090 |
Why?
|
Catalase | 1 | 2009 | 85 | 0.090 |
Why?
|
Fever | 1 | 2010 | 96 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 300 | 0.080 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 2 | 2006 | 16 | 0.080 |
Why?
|
Tissue Distribution | 2 | 2010 | 282 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2013 | 334 | 0.080 |
Why?
|
Paraquat | 2 | 2006 | 8 | 0.080 |
Why?
|
Adenosine Diphosphate | 2 | 2022 | 66 | 0.080 |
Why?
|
Male | 14 | 2019 | 37283 | 0.080 |
Why?
|
Macrophages | 2 | 2009 | 647 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2009 | 108 | 0.080 |
Why?
|
Immunoprecipitation | 4 | 2012 | 132 | 0.080 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 274 | 0.080 |
Why?
|
Biomarkers, Tumor | 1 | 2012 | 508 | 0.080 |
Why?
|
Enzyme Activation | 5 | 2013 | 791 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2009 | 250 | 0.080 |
Why?
|
Antioxidants | 3 | 2005 | 304 | 0.080 |
Why?
|
Motor Activity | 1 | 2011 | 621 | 0.080 |
Why?
|
Meglumine | 1 | 2007 | 16 | 0.070 |
Why?
|
Time Factors | 3 | 2005 | 4655 | 0.070 |
Why?
|
Molecular Conformation | 1 | 2007 | 128 | 0.070 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 136 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 204 | 0.070 |
Why?
|
Membrane Lipids | 3 | 1987 | 31 | 0.070 |
Why?
|
Child, Preschool | 1 | 2014 | 3187 | 0.070 |
Why?
|
Hypoxia | 2 | 2005 | 169 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2010 | 286 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2005 | 618 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 331 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2007 | 34 | 0.070 |
Why?
|
Epithelial Cells | 4 | 2013 | 431 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 6 | 2009 | 2083 | 0.070 |
Why?
|
Cocaine | 1 | 2011 | 555 | 0.070 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2017 | 99 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 200 | 0.070 |
Why?
|
Aged | 3 | 2019 | 14842 | 0.070 |
Why?
|
Lung Injury | 1 | 2006 | 38 | 0.070 |
Why?
|
Oxidants | 2 | 2003 | 48 | 0.070 |
Why?
|
Thiobarbituric Acid Reactive Substances | 4 | 2006 | 17 | 0.060 |
Why?
|
Electrons | 1 | 2005 | 25 | 0.060 |
Why?
|
Young Adult | 2 | 2014 | 5710 | 0.060 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2006 | 117 | 0.060 |
Why?
|
Mice, SCID | 2 | 2018 | 238 | 0.060 |
Why?
|
Calcium Channels, T-Type | 1 | 2004 | 1 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 248 | 0.060 |
Why?
|
Ion Transport | 1 | 2004 | 26 | 0.060 |
Why?
|
Mechanotransduction, Cellular | 1 | 2004 | 27 | 0.060 |
Why?
|
Protein Interaction Mapping | 2 | 2016 | 62 | 0.060 |
Why?
|
Lung Diseases | 1 | 2006 | 175 | 0.060 |
Why?
|
Models, Chemical | 1 | 2005 | 155 | 0.060 |
Why?
|
Binding Sites | 1 | 2005 | 631 | 0.060 |
Why?
|
Adenoviridae | 1 | 2004 | 295 | 0.060 |
Why?
|
Respiratory Mucosa | 1 | 2003 | 52 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2013 | 1533 | 0.050 |
Why?
|
Intracellular Membranes | 1 | 2003 | 86 | 0.050 |
Why?
|
Aorta | 1 | 2004 | 316 | 0.050 |
Why?
|
Ribose | 1 | 2022 | 1 | 0.050 |
Why?
|
Peroxides | 1 | 2022 | 23 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2022 | 39 | 0.050 |
Why?
|
Homologous Recombination | 1 | 2022 | 13 | 0.050 |
Why?
|
Dimerization | 3 | 2008 | 99 | 0.050 |
Why?
|
Cation Transport Proteins | 1 | 2002 | 11 | 0.050 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2002 | 29 | 0.050 |
Why?
|
Genetic Therapy | 1 | 2004 | 291 | 0.050 |
Why?
|
DNA Repair | 1 | 2022 | 127 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2003 | 765 | 0.050 |
Why?
|
Ligands | 2 | 2014 | 317 | 0.050 |
Why?
|
Adolescent | 1 | 2014 | 8904 | 0.050 |
Why?
|
Cell Survival | 2 | 2017 | 901 | 0.050 |
Why?
|
Female | 6 | 2014 | 38021 | 0.050 |
Why?
|
Drug Combinations | 2 | 2012 | 304 | 0.040 |
Why?
|
Protein Structure, Tertiary | 3 | 2007 | 322 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 1446 | 0.040 |
Why?
|
Stress, Mechanical | 3 | 2005 | 208 | 0.040 |
Why?
|
DNA | 1 | 2022 | 597 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2010 | 93 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 1293 | 0.040 |
Why?
|
Phosphorylation | 3 | 2009 | 1200 | 0.040 |
Why?
|
Membrane Potentials | 3 | 2004 | 200 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 140 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2002 | 415 | 0.040 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2018 | 25 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 138 | 0.040 |
Why?
|
Adult | 2 | 2014 | 21379 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 48 | 0.040 |
Why?
|
Radiation Exposure | 1 | 2019 | 84 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 170 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2006 | 1033 | 0.040 |
Why?
|
Protein Folding | 2 | 2009 | 82 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 110 | 0.040 |
Why?
|
Cell Respiration | 1 | 2017 | 47 | 0.040 |
Why?
|
Necrosis | 2 | 2009 | 239 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 852 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2009 | 261 | 0.040 |
Why?
|
Drug Synergism | 1 | 2017 | 260 | 0.040 |
Why?
|
Pulmonary Surfactants | 2 | 2007 | 41 | 0.030 |
Why?
|
Fluorescent Dyes | 4 | 2003 | 191 | 0.030 |
Why?
|
Middle Aged | 1 | 2014 | 21119 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2009 | 1082 | 0.030 |
Why?
|
Lipid Peroxides | 2 | 2007 | 19 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2003 | 2550 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 1745 | 0.030 |
Why?
|
Protein Transport | 1 | 2016 | 280 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2005 | 16 | 0.030 |
Why?
|
Mice, Mutant Strains | 2 | 2005 | 166 | 0.030 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2014 | 19 | 0.030 |
Why?
|
Cromakalim | 2 | 2004 | 2 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2014 | 48 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 51 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 467 | 0.030 |
Why?
|
Mice, Nude | 1 | 2014 | 294 | 0.030 |
Why?
|
Glutaredoxins | 1 | 2013 | 12 | 0.030 |
Why?
|
Isoenzymes | 2 | 2007 | 308 | 0.030 |
Why?
|
Nitrogen | 1 | 2013 | 57 | 0.030 |
Why?
|
Lipoproteins, HDL | 2 | 1985 | 113 | 0.030 |
Why?
|
NADP | 1 | 2013 | 39 | 0.030 |
Why?
|
Lipid Bilayers | 1 | 2013 | 24 | 0.030 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2013 | 22 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2013 | 68 | 0.030 |
Why?
|
S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
Blotting, Western | 2 | 2004 | 954 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2013 | 326 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 247 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 314 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 139 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 160 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 324 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2011 | 75 | 0.020 |
Why?
|
Actins | 1 | 2012 | 249 | 0.020 |
Why?
|
Liver | 1 | 2016 | 1118 | 0.020 |
Why?
|
Labor Stage, First | 1 | 2010 | 5 | 0.020 |
Why?
|
Seizures, Febrile | 1 | 2010 | 10 | 0.020 |
Why?
|
Glutathione Reductase | 1 | 2010 | 17 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 37 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 189 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2010 | 55 | 0.020 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2009 | 7 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2009 | 30 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 306 | 0.020 |
Why?
|
Cell Extracts | 1 | 2009 | 21 | 0.020 |
Why?
|
Protein Subunits | 1 | 2009 | 99 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 50 | 0.020 |
Why?
|
Threonine | 1 | 2009 | 47 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2009 | 99 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 2010 | 91 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 138 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 329 | 0.020 |
Why?
|
Imidazoles | 1 | 2009 | 175 | 0.020 |
Why?
|
Indoles | 1 | 2009 | 146 | 0.020 |
Why?
|
Endocytosis | 1 | 2009 | 113 | 0.020 |
Why?
|
Sphingolipids | 1 | 2011 | 337 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2009 | 270 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 434 | 0.020 |
Why?
|
Sorbitol | 1 | 2007 | 3 | 0.020 |
Why?
|
Ceramides | 1 | 2011 | 578 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 267 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 215 | 0.020 |
Why?
|
Amino Sugars | 1 | 2007 | 12 | 0.020 |
Why?
|
Proteomics | 1 | 2009 | 246 | 0.020 |
Why?
|
Membranes, Artificial | 2 | 1985 | 88 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 85 | 0.020 |
Why?
|
Influenza A virus | 1 | 1987 | 13 | 0.020 |
Why?
|
Erythrocytes | 1 | 2007 | 137 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 381 | 0.020 |
Why?
|
Parturition | 1 | 2007 | 15 | 0.020 |
Why?
|
Sepsis | 1 | 2010 | 233 | 0.020 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2007 | 17 | 0.020 |
Why?
|
Mesothelioma | 1 | 2007 | 21 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 624 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.020 |
Why?
|
Enzyme Reactivators | 1 | 2006 | 1 | 0.020 |
Why?
|
Protein Carbonylation | 1 | 2006 | 2 | 0.020 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 2005 | 9 | 0.020 |
Why?
|
Sepharose | 1 | 2005 | 18 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2010 | 1549 | 0.020 |
Why?
|
Nickel | 1 | 2005 | 18 | 0.020 |
Why?
|
Chromatography | 1 | 2005 | 47 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2005 | 30 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 50 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2005 | 50 | 0.020 |
Why?
|
NADPH Oxidase 2 | 1 | 2005 | 16 | 0.020 |
Why?
|
Glyburide | 1 | 2005 | 19 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2010 | 1034 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2005 | 20 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2005 | 80 | 0.020 |
Why?
|
Lysosomes | 1 | 2006 | 136 | 0.020 |
Why?
|
Light | 1 | 2005 | 152 | 0.020 |
Why?
|
Mibefradil | 1 | 2004 | 1 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2005 | 107 | 0.020 |
Why?
|
Gene Targeting | 1 | 2004 | 58 | 0.020 |
Why?
|
Nifedipine | 1 | 2004 | 40 | 0.020 |
Why?
|
Potassium Channel Blockers | 1 | 2004 | 32 | 0.020 |
Why?
|
Rheology | 1 | 2004 | 25 | 0.020 |
Why?
|
Thermodynamics | 1 | 1985 | 162 | 0.020 |
Why?
|
Cytochromes c | 1 | 2004 | 75 | 0.020 |
Why?
|
Angiotensin II | 1 | 2005 | 220 | 0.020 |
Why?
|
Ion Channel Gating | 1 | 2004 | 42 | 0.020 |
Why?
|
Cell Division | 1 | 2005 | 541 | 0.020 |
Why?
|
Potassium Channels | 1 | 2004 | 55 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 2334 | 0.010 |
Why?
|
Pseudogenes | 1 | 2003 | 4 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 77 | 0.010 |
Why?
|
Capillaries | 1 | 2004 | 105 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 2455 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2003 | 25 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 137 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2003 | 85 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 160 | 0.010 |
Why?
|
Introns | 1 | 2003 | 68 | 0.010 |
Why?
|
Organ Size | 1 | 2004 | 242 | 0.010 |
Why?
|
Pleural Effusion | 1 | 2004 | 74 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2003 | 67 | 0.010 |
Why?
|
Organ Specificity | 1 | 2003 | 167 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
Organophosphorus Compounds | 1 | 2003 | 13 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2004 | 138 | 0.010 |
Why?
|
Peroxidase | 1 | 2003 | 40 | 0.010 |
Why?
|
Pyrenes | 1 | 2003 | 15 | 0.010 |
Why?
|
Vitamin E | 1 | 2003 | 55 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2004 | 489 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 196 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 714 | 0.010 |
Why?
|
Fluorescence | 1 | 2003 | 104 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 370 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 312 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 282 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 492 | 0.010 |
Why?
|
Partial Pressure | 1 | 2002 | 19 | 0.010 |
Why?
|
Lanthanum | 1 | 2002 | 3 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2005 | 361 | 0.010 |
Why?
|
Hyperbaric Oxygenation | 1 | 2002 | 11 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2002 | 13 | 0.010 |
Why?
|
Phosphatidylinositols | 1 | 2002 | 40 | 0.010 |
Why?
|
Phenotype | 1 | 2005 | 946 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 88 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2002 | 54 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1982 | 38 | 0.010 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2002 | 35 | 0.010 |
Why?
|
Calcium Channels | 1 | 2002 | 59 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 66 | 0.010 |
Why?
|
Sphingomyelins | 1 | 1982 | 106 | 0.010 |
Why?
|
Cytoplasm | 1 | 2002 | 155 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2002 | 91 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 204 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 770 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 1055 | 0.010 |
Why?
|
Tyrosine | 1 | 2002 | 196 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 371 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 473 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 782 | 0.010 |
Why?
|
Rimantadine | 1 | 1987 | 3 | 0.000 |
Why?
|
Viral Matrix Proteins | 1 | 1987 | 10 | 0.000 |
Why?
|
Membranes | 1 | 1987 | 26 | 0.000 |
Why?
|
Photochemistry | 1 | 1987 | 46 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1987 | 70 | 0.000 |
Why?
|
Chickens | 1 | 1987 | 232 | 0.000 |
Why?
|
Viral Proteins | 1 | 1987 | 149 | 0.000 |
Why?
|
Membrane Fluidity | 1 | 1982 | 13 | 0.000 |
Why?
|
Fluorescence Polarization | 1 | 1982 | 14 | 0.000 |
Why?
|
Energy Transfer | 1 | 1982 | 25 | 0.000 |
Why?
|
Protein Conformation | 1 | 1982 | 362 | 0.000 |
Why?
|